National Workshop on Alternatives to Animal Testing in Drug Discovery at JSS University | September 2-3,2013
Alternatives to animal testing in drug discovery are primarily based on biochemical assays, on experiments in cells that are carried out in vitro and on computational models and algorithms.


Glenmark Pharmaceuticals today announced the settlement of litigation with Daiichi Sankyo and Genzyme Corporation regarding Glenmark's Abbreviated New Drug Application (ANDA) tiled with the US Food and Drug Administration (FDA) for Colesevelam Hydrochloride, a drug used in treatment of type-2 diabetes.

